Literature DB >> 11527611

Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era.

N Mercado1, E Boersma, W Wijns, B J Gersh, C A Morillo, V de Valk, G A van Es, D E Grobbee, P W Serruys.   

Abstract

OBJECTIVES: We sought to assess whether coronary stents have modified the predictive value of demographic, clinical and quantitative coronary angiographic (QCA) predictors of coronary restenosis.
BACKGROUND: A systematic analysis in a large cohort of registries and randomized trials of the percutaneous transluminal coronary angioplasty (PTCA) and stent era has never been performed.
METHODS: A total of 9,120 treated lesions in 8,156 patients included in nine randomized trials and 10 registries, with baseline, post-procedural and six-month follow-up QCA analyses, were included in this study. Predictors of restenosis were identified with univariate and multivariate logistic regression analyses. Interaction terms were introduced in the regression equation to evaluate whether the predictors of restenosis were common to both eras or specific for either one of the revascularization techniques.
RESULTS: The restenosis rate was 35% after PTCA and 19% after angioplasty with additional stenting. In the univariate analysis, favorable predictors were previous coronary artery bypass graft surgery (CABG), stent use, stent length and a large pre-procedural minimal lumen diameter (pre-MLD); unfavorable predictors were weight, body mass index, diabetes mellitus, multi-vessel disease, lesion length and a high residual post-procedural diameter stenosis (post-DS). Predictors specific for the PTCA population were a large post-procedural MLD (post-MLD) as favorable and a severe pre-procedural DS (pre-DS) as unfavorable. Favorable predictors specific for the stent population were a large post-MLD and a large pre-procedural reference diameter (pre-RD). In the multivariate analysis, the best model included the following favorable predictors: stent use, a large post-MLD, previous CABG and the interaction term between stent use and a large post-MLD; unfavorable predictors were lesion length and diabetes mellitus.
CONCLUSIONS: There are no major differences in demographic and clinical predictors of coronary restenosis between PTCA and stent populations. In the modern (stent) era, a severe pre-DS is no longer an unfavorable predictor of restenosis. Still important, but more so in the stent population, is a large post-MLD (optimal result). Finally, a larger pre-RD became a favorable predictor with the advent of stenting.

Entities:  

Mesh:

Year:  2001        PMID: 11527611     DOI: 10.1016/s0735-1097(01)01431-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

1.  Drug eluting stents: maximising benefit and minimising cost.

Authors:  J Gunn; A C Morton; C Wales; C M H Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

2.  The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.

Authors:  Ralf Zahn; C W Hamm; S Schneider; U Zeymer; G Richardt; M Kelm; B Levenson; T Bonzel; U Tebbe; G Sabin; C A Nienaber; Thomas Pfannebecker; J Senges
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

3.  Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registry.

Authors:  Ranjan Shetty; G Vivek; Ashok Thakkar; Supriya Sunder Mishra; Vivek Joseph; Mithun Gopal Devraj; Anil Tumkur; Umesh Pai
Journal:  J Clin Diagn Res       Date:  2013-09-10

4.  Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.

Authors:  Elena V Zholdybayeva; Yerkebulan A Talzhanov; Akbota M Aitkulova; Pavel V Tarlykov; Gulmira N Kulmambetova; Aisha N Iskakova; Aliya U Dzholdasbekova; Olga A Visternichan; Dana Zh Taizhanova; Yerlan M Ramanculov
Journal:  Hum Genomics       Date:  2016-06-08       Impact factor: 4.639

Review 5.  Novel QCA methodologies and angiographic scores.

Authors:  Vivian G Ng; Alexandra J Lansky
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-20       Impact factor: 2.357

6.  Coronary in-stent restenosis: predisposing clinical and stent-related factors, diagnostic performance and analyses of inaccuracies in 320-row computed tomography angiography.

Authors:  Yung-Liang Wan; Pei-Kwei Tsay; Chun-Chi Chen; Yu-Hsiang Juan; Yu-Chieh Huang; Wen-Hui Chan; Ming-Shien Wen; I-Chang Hsieh
Journal:  Int J Cardiovasc Imaging       Date:  2016-04-22       Impact factor: 2.357

7.  Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)--registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

Authors:  Ralf Zahn; Thomas Ischinger; Uwe Zeymer; Johannes Brachmann; Jens Jung; Hartwig Haase; Karl Eugen Hauptmann; Hubert Seggewiss; Ilse Janicke; Matthias Leschke; Harald Mudra
Journal:  Clin Res Cardiol       Date:  2010-07-02       Impact factor: 5.460

8.  Does a well developed collateral circulation predispose to restenosis after percutaneous coronary intervention? An intravascular ultrasound study.

Authors:  D Perera; P Postema; R Rashid; S Patel; L Blows; M Marber; S Redwood
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

9.  Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.

Authors:  C-K Wong; C J K Hammett; R The; J K French; W Gao; B J Webber; J M Elliott; A W Hamer; J A Ormiston; M W I Webster; R A H Stewart; R V Ameratunga; H D White
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

10.  A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients.

Authors:  Ashok Seth; Praveen Chandra; Nagendra S Chouhan; Ashok S Thakkar
Journal:  Indian Heart J       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.